Skip to main content

Table 2 Characteristics of study participants with alcoholic liver disease in patients with excessive alcohol consumption compared to non-alcoholic fatty liver disease

From: The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database

 

Alcoholic liver disease

Non-alcoholic fatty liver disease

p value

N = 52

N = 506

Age (years)—mean (95% CI)

30.02 (28.80–31.25)

30.00 (29.28–30.72)

0.968

Male—% (95% CI)

74.10 (56.42–86.34)

58.09 (50.92–64.92)

0.115

BMI (kg/m2)—mean (95% CI)

32.65 (30.98–34.31)

34.116 (32.80–35.43)

0.109

Race/ethnicity—% (95% CI)

Non-Hispanic White

65.784 (51.21–77.89)

50.39 (41.47–59.28)

0.056

Non-Hispanic Black

5.368 (1.50–17.41)

9.56 (5.91–15.11)

 

Hispanic

21.129 (12.96–32.52)

29.08 (21.19–38.49)

 

Non-Hispanic Asian

0.554 (0.07–4.25)

6.14 (4.15–8.98)

 

Non-Hispanic other

7.164 (2.29–20.29)

4.83 (3.23–7.16)

 

Smoking status—% (95% CI)

Never

26.66 (12.77–47.44)

59.88 (51.56–67.67)

 < 0.001

Former

12.31 (4.83–27.98)

22.4 (16.56–29.56)

 

Current

61.03 (45.18–74.85)

17.72 (12.97–23.74)

 

Lab values—mean (95% CI)

Total bilirubin (mg/dL)

0.45 (0.31–0.59)

0.46 (0.41–0.5)

0.905

AST (IU/L)

33.81 (21.67–45.95)

23.9 (22.4–25.4)

0.087

ALT (IU/L)

41.55 (26.48–56.62)

31.15 (27.29–35.01)

0.142

Albumin (g/dL)

4.2 (4.11–4.3)

4.14 (4.06–4.22)

0.379

MCV (fL)

89.8 (87.72–91.88)

86.34 (85.53–87.15)

0.002

Platelet count (103 cells/uL)

260.16 (240.48–279.85)

265.58 (254.51–276.64)

0.591

HbA1C (%)

5.38 (5.13–5.63)

5.46 (5.37–5.55)

0.548